维普期刊资源整合服务平台（V6.5）

188篇 您的检索式：作者名="Guilhot F"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O'Brien S G Guilhot F Larson R A		New England Journal of Medicine0，，：	1
2	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	Druker BJ Guilhot F O'Brien SG		0，，：	1
3	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Druker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
4	Indications for imatinib mesylate therapy and clinical management 显示文摘	Guilhot F	2004	Oncologist2004，9，3：	1
5	Imatinib compared with interferon and low-dose eytarabine for newly diagnosed chronic-phase chronic myeloid leukemia 显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
6	Imatinib Pharmaeokineties and Its Correlation with Response and Safety in Chronic-phase Chronic Myeloid Leukemia: a Subanalysis of the IRIS Study显示文摘	Larson RA Druker B J Guilhot F	2008	Blood2008，111，8：	1
7	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia 显示文摘	Dntker B J Guilhot F O' Brien SG	2006	N Engl J Med2006，355，23：	1
8	Five-year follow-up of pa- tients receiving imatinib for chronic myeloid leukemia显示文摘	Druker B J Guilhot F OBrien SG	2006	N Engl J Med2006，355，23：	1
9	Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase显示文摘	Kantarjian HM Larson RA Guilhot F	2009	Caneer2009，115，3：	1
10	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O· Brien SG Guilhot F Larson RA	2003	N EnglJMed2003，348，11：	1
11	Imatinib com- pared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia 显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
12	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，11：	1
13	Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia显示文摘	Hochhaus A O'Brien SG Guilhot F	2009	Leukemia2009，23，6：	1
14	:Imatinib compared withinterferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘	O'Brien SG Guilhot F Larson RA	2003	N Engl J Med2003，348，99：	1
15	:Six-year follow-up ofpatients receiving imatinib for the first-line treatment of chronic mye-loid leukemia显示文摘	Hochhaus A O'Brien SG Guilhot F	2009	Leukemia2009，23，10：	1
16	Five-year fol-low-up of patients receiving imatinib for chronic myeloid leukemia显示文摘	DRUKER BJ GUILHOT F O'BRIEN SG	2006	N Engl J Med2006，355，23：	1
17	Imatinib phar-macokinetics and its correlation with response and safety inchronic-phase chronic myeloid leukemia:a subanalysis of theIRIS study显示文摘	LARSON RA DRUKER BJ GUILHOT F	2008	Blood2008，111，8：	1
18	Interferon alfa-2b combined with cytarrabine versus interferon alone in chronic myelogenors leukemia显示文摘	Guilhot F Chastang C Michallet M	1997	N Engl J Med1997，337，：	1
19	Immunotherapeutic approaches in chronic myelogenous leukemia显示文摘	Guilhot F Roy L Saulnier PJ	2008	Leuk Lymphoma2008，49，4：	1
20	BCR/ABL promotes dendritic cell-mediated natural killer cell activation 显示文摘	Terme M Borg C Guilhot F	2005	Cancer Res2005，65，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示